What Vision Therapy for Convergence Insufficiency Actually Costs
The Cost of Vision Therapy for Convergence Insufficiency at a Glance
You want a number. Here it is. In the United States in 2026, a full course of office-based vision therapy for convergence insufficiency usually runs a few thousand dollars. As of 2025 in the United States, a price survey found sessions of about 75 to 175 dollars each, an average first visit near 322 dollars, and a typical total of about 2,762 to 3,982 dollars for 20 to 30 visits, though prices vary widely by state and practice.1 Home and online programs cost far less. Good plans often pay for part of the care.
Two people can pay very different amounts for the same diagnosis. The gap comes from where you live, who treats you, how many visits you need, and how much your plan pays. Convergence insufficiency is an eye-teaming problem in which the eyes drift outward during reading or near work, and the treatment that works best combines home exercises plus in-office therapy.2 The in-office part is the part that costs money, so the number of office visits drives most of your bill.
Start with a diagnosis, not a price shop. Ask for a functional or binocular vision exam to confirm the problem and to count how many office sessions you are likely to need. Convergence insufficiency is very treatable when it is diagnosed, but the therapy only helps if the exercises are actually done.2 Then call your insurer with the diagnosis code and ask, in writing, how many sessions they will cover.
What Convergence Insufficiency and Its Therapy Are
Convergence is the way your two eyes turn inward to aim at something close, like a book or a phone. In convergence insufficiency the eyes struggle to hold that inward aim, which can cause eyestrain, headaches, blurred or double vision, loss of place while reading, and words that seem to move on the page.2 These symptoms are uncomfortable and can make school or desk work harder, but they are not dangerous and they respond well to treatment.
Vision therapy is a supervised program of eye exercises. You usually go once a week, and you do more exercises at home between visits. The American Optometric Association describes the most successful approach as home plus office therapy, with results that usually last once the program is done.2 At the office visits, a trained therapist guides the exercises and makes them harder over time. That guidance is the main reason office care works better than exercises done alone.
This is not a rare, exotic problem, which is part of why so many families end up pricing it out. Estimates suggest convergence insufficiency affects up to about 15 of every 100 school-age children.3 Adults get it too, especially with heavy screen use or after a concussion. Because it is common and often missed, a proper exam is worth more than a quick online self-test.
What You Will Actually Pay
Most of your bill is simply sessions multiplied by the per-session price. As of 2025, one Wisconsin practice in the United States lists office sessions at about 175 to 200 US dollars each and total treatment of about 1,000 to 9,000 US dollars, depending on how much care a person needs.4 That wide range is normal: a straightforward case may need a dozen visits, while a complex case, or one paired with other eye-teaming or focusing problems, needs more.
Before therapy starts, there is a fee for the exam that measures the problem and builds the plan. As of 2025 in the United States, a price survey put the average initial vision therapy consultation near 322 US dollars, though it ranged widely by state and practice.1 This evaluation is not wasted money even if you choose not to proceed, because it tells you whether convergence insufficiency is truly the cause and rules out other conditions that need different care.
Coverage exists, but it is capped and it depends on your specific plan. Under Capital BlueCross Medical Policy MP 4.007, effective April 1, 2026, up to 12 sessions of office-based vision therapy for symptomatic convergence insufficiency are considered medically necessary, while more than 24 sessions per occurrence are considered investigational.5 Other medical plans set their own limits, so this is an example, not a promise about your plan. Vision therapy is usually billed to medical insurance, not to a routine vision plan.
You have real levers here. Ask whether a home or online program is appropriate for your case, since those cost far less than weekly office visits. As of 2025 in the United States, Washington University in St. Louis lists its HTS2 online home-based vision therapy program at 599 US dollars, with a 75 US dollar fee for the initial appointment, and prices may change over time.6 You can also use a health savings or flexible spending account, ask about payment plans, and confirm the diagnosis is billed to medical rather than vision insurance.
Comparing the Cost of Your Treatment Options
The cheapest option is not always the best value, because a low success rate can mean paying twice. The table below pairs rough US 2026 price ranges with what the research shows about results.
| Option | Rough cost (US, 2026) | What the evidence shows |
|---|---|---|
| Office-based therapy plus home practice | About 1,000 to 4,000 dollars for a course | Highest success in the CITT |
| Home computer program plus pencil push-ups | A few hundred dollars | Lower success in the CITT |
| Pencil push-ups alone | Little to no cost | Weakest of the studied options |
In the CITT, a trial of 221 children aged 9 to 17, about 75 of every 100 who did 12 weeks of office-based therapy with home reinforcement improved, versus about 33 of every 100 who used home pencil push-ups plus a computer program.7 So the pricier option also had the strongest results in that study.
Cost should be weighed against how likely each path is to actually fix your symptoms. Most studies show that a short course of therapy helps symptoms, that longer therapy adds no extra benefit, and that most patients never need surgery.8 A motivated adult with a mild case may do well with a supervised home or online program, while a child who struggles to keep up exercises alone often gets more value from guided office sessions.
What the Money Buys: Value and Realistic Outlook
It helps to know what a normal outcome looks like before you spend. In the CITT, roughly 75 of every 100 children given office-based therapy with home practice reached normal measures or had clearly fewer symptoms after 12 weeks.7 That is a population average from one study, not a personal guarantee, but it means a well-run office program has a strong track record for reducing reading strain and related symptoms.
Spending less up front can cost more if the symptoms come back. A home-only or pencil push-up plan is cheap, but its lower success rate means some people finish it still symptomatic and then pay again for office care. The American Optometric Association describes the most successful approach as combining home plus in-office therapy.2 A home-only plan skips that supervised office component, so if you choose the low-cost route, set a check-in date so you are not stuck repeating exercises that are not working.
Value is about durable relief, not just the sticker price. Convergence therapy that works tends to produce lasting improvement in symptoms without ongoing treatment, and most patients do not need surgery.8 For a person whose reading, work, or schooling is genuinely limited by eyestrain and double vision, a few thousand dollars for a proven course of care is often worth it, especially where insurance covers part of the sessions.
When to See a Doctor and Who to See
Ongoing eyestrain, headaches, or double vision during reading deserve an exam rather than another guess at a price. These are the classic convergence insufficiency symptoms, and they are treatable, so there is no reason to wait months. Convergence insufficiency causes eyestrain, headaches, blurred or double vision, and loss of place while reading, and it is very treatable once it is properly diagnosed.2 Book a functional or binocular vision exam if these symptoms keep interfering with near work.
Some symptoms point to a different problem and should be seen the same day, not booked as therapy. Sudden double vision that starts out of nowhere, double vision with a severe headache, drooping eyelid, facial weakness, or new double vision after a head injury are not part of routine convergence insufficiency and can signal a neurological problem. Contact an eye doctor or urgent care promptly for these, because getting the right diagnosis quickly protects your vision and, in some cases, your health.
Convergence insufficiency care usually goes beyond a basic vision screening, so the right provider matters. The American Optometric Association describes vision therapy for convergence insufficiency as a supervised program that combines in-office sessions with home practice.2 In practice it is usually provided by an optometrist who focuses on eye teaming or vision therapy, so ask a general optometrist or eye doctor to refer you to a provider who offers it. Confirm up front how they diagnose it, plan it, and bill it.
Common Questions About Vision Therapy Costs
Most of the cost is professional time: weekly one-on-one sessions with a trained therapist over several weeks, plus the initial evaluation. As of 2025 in the United States, a survey found sessions of about 75 to 175 US dollars each and typical totals near 2,762 to 3,982 US dollars across 20 to 30 visits, with prices varying by practice.1 You are paying for supervised, progressive care, which is also why office-based programs tend to work better than doing exercises alone at home.
Often, at least in part, but with limits that vary by plan. Capital BlueCross policy MP 4.007 counts up to 12 office-based sessions as medically necessary for symptomatic convergence insufficiency and treats more than 24 sessions as investigational.5 Because rules differ by payer, call your medical insurer, give them the diagnosis, and ask exactly how many sessions are covered and what your share will be.
You can try, and for some people it helps, but expect a lower success rate. In the CITT, about 33 of every 100 children improved with home pencil push-ups plus a computer program, compared with about 75 of every 100 who did office-based therapy with home practice.7 If a home program does not clearly help within a few weeks, treat that as a signal to add supervised office care rather than pushing on.
A structured online program can be a reasonable, lower-cost option for the right case. As of 2025 in the United States, Washington University in St. Louis offers an HTS2 online home-based vision therapy program priced at 599 US dollars, with a 75 US dollar initial appointment fee.6 It costs far less than weekly office visits, but online and home programs generally suit motivated patients who reliably do the exercises; ask your eye doctor whether your case fits that profile.
It depends on the severity of your case and whether other focusing problems are present. One payer's medical policy, for example, counts up to 12 office-based sessions as the medically necessary range for symptomatic convergence insufficiency.5 Your provider should estimate your session count after the evaluation, so ask for that number, and the expected total cost, before you begin.
More Questions About Paying for Care
Yes. Medically necessary vision therapy for a diagnosed condition is generally an eligible expense for a health savings account or flexible spending account, which lets you pay with pre-tax dollars. Keep the diagnosis, the treatment plan, and itemized receipts, and check your account rules, since some plans want a letter of medical necessity from your provider. This does not lower the sticker price, but it can meaningfully reduce what the care effectively costs you.
No, prices vary a lot by state and by practice. As of 2025 in the United States, a survey of practices found initial consultations ranging from about 100 to nearly 900 US dollars and per-session fees from about 75 to 175 US dollars, varying by state.1 It is reasonable to ask two or three practices for their evaluation fee, per-session fee, and estimated number of sessions, then compare total expected cost rather than the per-session price alone.
For symptomatic people, it usually is, because the relief tends to last. Most studies show a short course of therapy helps symptoms, longer therapy adds no extra benefit, and most patients do not need surgery.8 If reading or screen work is genuinely limited by eyestrain and double vision, a proven course of care, partly covered by insurance, is often a better value than years of unmanaged symptoms.
- Do I clearly have convergence insufficiency, or could another condition be causing my symptoms?
- How many office sessions do you estimate I will need, and what is the expected total cost?
- Is a supervised home or online program appropriate for my case?
- Will you bill my medical insurance, and can you help me confirm how many sessions are covered?
- What should improve, and by when, so I know the therapy is working?
- What happens, and what does it cost, if my symptoms return later?
- Strabismus Solutions (US survey of practice prices) (2025). Cost of Vision Therapy: Examples from all 50 States.
- American Optometric Association (AOA) (2024). Convergence Insufficiency.
- Optometrists.org (2023). Understanding Convergence Insufficiency.
- The Vision Therapy Center (Wisconsin, US) (2025). Vision Therapy Costs.
- Capital BlueCross Medical Policy MP 4.007 (2026). Medical Policy: Vision Therapy (MP 4.007).
- Washington University in St. Louis, Department of Ophthalmology & Visual Sciences (2025). Online Vision Therapy (HTS2).
- Optometrists.org (summary of the NEI-funded CITT) (2023). Convergence Insufficiency Treatment Trial (CITT).
- American Association for Pediatric Ophthalmology and Strabismus (AAPOS) (2024). Convergence Insufficiency.